These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 12183683

  • 1. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

  • 2. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 3. EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties.
    Bartoszyk GD, Hegenbart R, Ziegler H.
    Eur J Pharmacol; 1997 Mar 19; 322(2-3):147-53. PubMed ID: 9098681
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C, Seyfried CA.
    Psychopharmacology (Berl); 2014 Jun 19; 231(12):2547-58. PubMed ID: 24419272
    [Abstract] [Full Text] [Related]

  • 5. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, Zgombick JM, Xu YC.
    J Pharmacol Exp Ther; 2000 Aug 19; 294(2):688-700. PubMed ID: 10900249
    [Abstract] [Full Text] [Related]

  • 6. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA, Nguyen HQ, Smith DL, Schechter LE.
    J Psychopharmacol; 2002 Jun 19; 16(2):145-52. PubMed ID: 12095073
    [Abstract] [Full Text] [Related]

  • 7. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec 19; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.
    Ashby CR, Kehne JH, Bartoszyk GD, Renda MJ, Athanasiou M, Pierz KA, Seyfried CA.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):359-65. PubMed ID: 23872377
    [Abstract] [Full Text] [Related]

  • 9. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
    Sakaue M, Somboonthum P, Nishihara B, Koyama Y, Hashimoto H, Baba A, Matsuda T.
    Br J Pharmacol; 2000 Mar 15; 129(5):1028-34. PubMed ID: 10696105
    [Abstract] [Full Text] [Related]

  • 10. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM, Monge A, Del Río J, Lasheras B.
    Eur J Pharmacol; 2002 May 03; 442(1-2):63-71. PubMed ID: 12020683
    [Abstract] [Full Text] [Related]

  • 11. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E, Li H, Carr KD, Hiller JM.
    J Pharmacol Exp Ther; 2000 Feb 03; 292(2):684-91. PubMed ID: 10640306
    [Abstract] [Full Text] [Related]

  • 12. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA, Hen R, Blendy JA, Lucki I.
    J Pharmacol Exp Ther; 2001 Sep 03; 298(3):1092-100. PubMed ID: 11504806
    [Abstract] [Full Text] [Related]

  • 13. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain.
    Castro M, Diaz A, del Olmo E, Pazos A.
    Neuropharmacology; 2003 Jan 03; 44(1):93-101. PubMed ID: 12559126
    [Abstract] [Full Text] [Related]

  • 14. Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.
    Dawson LA, Watson JM.
    CNS Neurosci Ther; 2009 Jan 03; 15(2):107-17. PubMed ID: 19499624
    [Abstract] [Full Text] [Related]

  • 15. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
    Kantor S, Graf M, Anheuer ZE, Bagdy G.
    Eur Neuropsychopharmacol; 2001 Feb 03; 11(1):15-24. PubMed ID: 11226808
    [Abstract] [Full Text] [Related]

  • 16. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test.
    Rénéric JP, Bouvard M, Stinus L.
    Neuropsychopharmacology; 2001 Apr 03; 24(4):379-90. PubMed ID: 11182533
    [Abstract] [Full Text] [Related]

  • 17. Effect of vilazodone on 5-HT efflux and re-uptake in the guinea-pig dorsal raphe nucleus.
    Roberts C, Hagan JJ, Bartoszyk GD, Kew JN.
    Eur J Pharmacol; 2005 Jul 04; 517(1-2):59-63. PubMed ID: 15978574
    [Abstract] [Full Text] [Related]

  • 18. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R, Bramante M, Samanin R.
    Pharmacol Biochem Behav; 1996 May 04; 54(1):143-7. PubMed ID: 8728551
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A.
    J Med Chem; 2002 Sep 12; 45(19):4128-39. PubMed ID: 12213056
    [Abstract] [Full Text] [Related]

  • 20. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010 Sep 12; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.